Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMWXI6C)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
1847-00-3; N-(4-Methylphenyl)-2-oxo-2H-chromene-3-carboxamide; AC1LCCPS; BAS 00837919; Oprea1_724223; Oprea1_384928; 3-carboxamido coumarin, 12; CBDivE_000120; CHEMBL512843; AC1Q2M91; ZINC59647; BDBM29162; 2h-1-benzopyran-3-carboxamide,n-(4-methylphenyl)-2-oxo-; MolPort-000-375-219; RYYPYTSGWXNKDU-UHFFFAOYSA-N; N-(p-Tolyl)coumarin-3-carboxamide; N-(p-Tolyl)-3-coumarincarboxamide; STK709419; AKOS000533534; MCULE-3147355051; ST4011307; KB-284700; EU-0034745; 2-oxo-N-(p-tolyl)-2H-chromene-3-carboxamide
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
|||||||||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||||||||